http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 04 May 2022 07:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+and+SOLTI+Present+New+Clinical+Biomarker+Data+Demonstrating+Pelareorep%27s+Potential+to+Improve+the+Prognosis+of+Breast+Cancer+Patients+at+the+ESMO+Breast+Cancer+Meeting/20014078.html Wed, 04 May 2022 07:00:00 -0500 O.02608059 ONC ONCWF ONCWF ONCY http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/Press+Releases/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html for the full story. http://www.streetinsider.com/PRNewswire/Oncolytics+Biotech%C2%AE+Announces+Positive+Long-Term+Survival+Data+from+Phase+1b+Glioblastoma+Multiforme+Trial+at+the+AACR+Annual+Meeting/19894609.html Fri, 08 Apr 2022 13:05:00 -0500 A.14055798 A.35552990 A.39227604 ONC ONCWF ONCWF ONCY ONYN